Indexguy, With the resources available I’m no
Post# of 147959
(Total Views: 575)
Posted On: 11/10/2020 6:04:27 PM
Indexguy,
With the resources available I’m no surprised that cancer enrollment has not progressed.
BLA miss with Amarex stinks, but I’m optimistic that Dr Rahman will get it done.
Covid CD10 results should have been granted EUA, but FDA apparently has different rules for BP.
NP not perfect by a long shot, but navigating to CD12 completion.
The only criticisms about which I agree unequivocally are overly optimistic messaging and failure to address BLA failures more objectively and aggressively
Nonetheless, we are where we are and I’m content/resigned to wait for CD12 results. No other choice and I’m not selling.
With the resources available I’m no surprised that cancer enrollment has not progressed.
BLA miss with Amarex stinks, but I’m optimistic that Dr Rahman will get it done.
Covid CD10 results should have been granted EUA, but FDA apparently has different rules for BP.
NP not perfect by a long shot, but navigating to CD12 completion.
The only criticisms about which I agree unequivocally are overly optimistic messaging and failure to address BLA failures more objectively and aggressively
Nonetheless, we are where we are and I’m content/resigned to wait for CD12 results. No other choice and I’m not selling.
(6)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼